| Literature DB >> 23162511 |
Emily Wiecek1, Louis R Pasquale, Jozsef Fiser, Steven Dakin, Peter J Bex.
Abstract
Natural vision involves sequential eye movements that bring the fovea to locations selected by peripheral vision. How peripheral visual field loss (PVFL) affects this process is not well understood. We examine how the location and extent of PVFL affects eye movement behavior in a naturalistic visual search task. Ten patients with PVFL and 13 normally sighted subjects with full visual fields (FVF) completed 30 visual searches monocularly. Subjects located a 4° × 4° target, pseudo-randomly selected within a 26° × 11° natural image. Eye positions were recorded at 50 Hz. Search duration, fixation duration, saccade size, and number of saccades per trial were not significantly different between PVFL and FVF groups (p > 0.1). A χ(2) test showed that the distributions of saccade directions for PVFL and FVL subjects were significantly different in 8 out of 10 cases (p < 0.01). Humphrey Visual Field pattern deviations for each subject were compared with the spatial distribution of eye movement directions. There were no significant correlations between saccade directional bias and visual field sensitivity across the 10 patients. Visual search performance was not significantly affected by PVFL. An analysis of eye movement directions revealed patients with PVFL show a biased directional distribution that was not directly related to the locus of vision loss, challenging feed-forward models of eye movement control. Consequently, many patients do not optimally compensate for visual field loss during visual search.Entities:
Keywords: and natural scenes; eye movements; glaucoma; low-vision; peripheral vision; visual search
Year: 2012 PMID: 23162511 PMCID: PMC3498877 DOI: 10.3389/fpsyg.2012.00472
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Peripheral visual field loss patient information and demographics.
| Subject | Age | Gender | Diagnosis | Eye | Visual acuity | MD (db) | PSD (db) | % Of positively correlated points | Standard deviations from FVF observer | Angle direction from FVF observer (°) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 83 | Female | POAG | L | 20/30 | −5.94 | 3.71 | 0.0001 | 68.63 | 1.46 | 68.15 |
| 2 | 82 | Female | CACG | R | 20/25 | −6.24 | 5.01 | 0.0911 | 69.23 | 1.21 | 86.88 |
| 3 | 82 | Female | POAG | R | 20/20 | −4.42 | 2.77 | <0.0001 | 74.51 | 2.25 | 83.38 |
| 4 | 58 | Female | ON drusen with treated OHTN | L | 20/20 | −6.53 | 7.27 | 0.0001 | 33.33 | 1.04 | 157.37 |
| 5 | 55 | Male | ON drusen with treated OHTN | R | 20/20 | −8.53 | 9.96 | 0.2308 | 76.92 | 1.02 | 73.02 |
| 6 | 74 | Female | Exfgl | L | 20/40 | −6.51 | 6.32 | <0.0001 | 76.47 | 0.86 | 55.12 |
| 7 | 67 | Male | POAG | L | 20/20 | −4.65 | 6.32 | 0.0001 | 58.82 | 0.95 | 57.55 |
| 8 | 79 | Male | POAG | L | 20/25 | −13.3 | 4.57 | 0.0023 | 78.85 | 1.21 | 73.47 |
| 9 | 58 | Male | Ang rec gl | L | 20/25 | −28.1 | 9.73 | 0.0006 | 80.39 | 6.49 | 79.35 |
| 10 | 45 | Female | POAG | L | 20/20 | −9.03 | 13.43 | 0.0029 | 67.31 | 1.05 | 71.72 |
Diagnoses: .
*Indicates subjects that did not have a distribution significantly different from FVF subjects based on the χ.
Figure 1Illustration of stimulus generation and example of typical eye movements. Left Column – Stimulus Generation: (middle) a Canny Edge Detector located the edges in a source image (top). A Gaussian weighting function (σ = 2°) was used to determine the mean number of edges in an area the size of the search target. This avoided the selection of targets with too few (e.g., blank regions of wall or sky) or too many (e.g., grass or blinds) features for localization. The green square (not shown in the experiment) illustrates the location of the search target selected with this method. Right Column – Display and Eye Movements: the target was placed in a window above the search image, its mean luminance (50 cd/m2) and rms contrast (0.2%) did not match the original in order to force a structural search. Fixations are depicted as blue circles, whose diameter represents fixation duration. Saccades are depicted as red vectors (not shown in the experiment). Example data are from Subject 5. Subjects were asked to locate the patch within the image and to click a mouse cursor on its location.
Figure 2Oculomotor summary measures. Box plots of search duration, fixation duration, saccade size, and number of saccades per second, averaged across peripheral visual field loss (PVFL) patient and full visual field (FVF) groups. The red line indicates the median for each distribution and the edges of the box display the 25th and 75th percentile. The red asterisk indicates the mean of each distribution and a red cross marks outliers. Comparison intervals are shown with notches. Whiskers display the minima and maxima of the distributions (excluding outliers). None of the parameters were significantly different between PVFL and FVF groups (p values and Bayes Factors shown inset). Bayes factors are listed in the form alternative/null.
Figure 3Binned saccade direction distributions and visual field sensitivity. The Columns A1 and A2 depict angle histograms for the distribution of saccade directions over all trials for each of the 10 PVFL patients. The FVF group histogram is centered above and is representative of a mean distribution for all FVF participants over all trials, with error bars to depict the standard error. Next to each histogram is a scatter plot of binned visual field sensitivity and binned saccade direction frequencies (eight bins of 45° each) for each PVFL patient. The red line represents the best-fit regression line.
Figure 4Visual field sensitivity and fixation landing points. The top rectangle contains data from the FVF group and the larger bottom rectangle contains data from each of the 10 PVFL patients. Column A shows the heat maps of visual sensitivity from Humphrey Visual Field test pattern deviations. Data collected from right eyes have been flipped for comparison purposes. Column B contains the relative frequency distribution of eye movements over all trials normalized to the center of visual field space. Frequencies are displayed as differences relative to the averaged FVF reference distribution. The top row of Column C includes a heat map of the standard deviation for fixation frequency across the 13 FVF observers to represent the variability across their distributions. Column C (rows 1–10) shows a point-wise comparison of visual field sensitivity and relative fixation frequency. The data are normalized as z-scores. The red diamond represents the location of a normally sighted observer (a summary estimate from the FVF group data).
| PVFL subjects | Classification | Acuity | Age | DX | Medications |
|---|---|---|---|---|---|
| 1 | Glaucoma | 20/30 | 83 | Overweight, hypertension, atrial fibrillation, lyme disease, chronic renal impairment, hiatal hernia, gastroesophageal reflux disease, colitis, gout, cervical disc disease, sciatica | |
| 2 | Glaucoma | 20/25 | 82 | Type 2 diabetes, atrial fibrillation, fuchs corneal dystrophy | |
| 3 | Glaucoma | 20/20 | 82 | Osteoporosis, glaucoma, cataract, hypercholesterolemia, HTN, ppd+/cxr+/−, gastritis | |
| 4 | Glaucoma | 20/20 | 58 | Hypertensive disorder, seasonal allergies | Caltrate, cardizem, losartan, mvi, simvastatin, |
| 5 | Glaucoma | 20/20 | 55 | Type 2 diabetes, cardiac catheterization, hypertension hypercholesterolemia, asthma, obesity, coronary artery disease, angioedema urticaria | Aspirin, coreg, epipen, flonase, lipitor, metformin, vitamin d3, |
| 6 | Glaucoma | 20/40 | 74 | Rheumatoid arthritis, depression, glaucoma, cirrhosis of liver, lymphadenopathy, scoliosis, kidney stone, osteopenia, hypertension | Aspirin, coreg, epipen, flonase, lipitor, metformin, vitamin d3, |
| 7 | Glaucoma | 20/20 | 67 | Rosacea, hypertension, glaucoma, elevated cholesterol | Clindamycin, diovan, hydrochlorothiazide, k-dur, metrogel, multivitamins, oxycodone, pravachol, timoptic, vitamin d3, xalatan |
| 8 | Glaucoma | 20/25 | 79 | Hypertension, elevated cholesterol, glaucoma, prostate cancer | Alphagan, aspirin, cosopt, flomax, hydrochlorothiazide, labetalol hcl, lipitor, lisinopril, |
| 9 | Glaucoma | 20/25 | 58 | Hypercholesterolemia, glaucoma, h/o myocardial infarction, placement of stent in coronary artery | |
| 10 | Glaucoma | 20/20 | 45 | Strabismus, glaucoma | Allegra, levoxyl, naproxen, nortriptyline hcl, |
| 1 | Suspect | 20/30 | 67 | Hypercholesterolemia, onychomycosis, glaucoma, right long apical scarring, alcoholism, smoking, hypertension, pulmonary nodule, asthma | |
| 2 | Suspect | 20/30 | 60 | Simvastatin | |
| 3 | Suspect | 20/20 | 64 | Prostate cancer | Multivitamins |
| 4 | Suspect | 20/25 | 44 | Arthritis, seasonal allergies, hernia repair, depression | Allegra, atenolol, diovan, imitrex, |
| 5 | Suspect | 20/30 | 83 | Hypertension, superficial phlebitis, raynauds, glaucoma, smoker, hypothyroidism, osteoporosis | |
| 6 | Suspect | 20/30 | 57 | H/O TOB 85, low hdl, drusen, colon, atrial fibrillation | Cipro, colace, dronedarone, flagyl, flomax, omeprazole, vancomycin hcl, |
| 7 | Suspect | 20/30 | 60 | Hypothyroidism | Aspirin, desonide, levoxyl, |
| 8 | Suspect | 20/20 | 49 | Depression, osteopenia, hypothyroidism, uterine leiomyoma, anemia | Calcium, desipramine, ferrous sulfate, levothyroxine sodium, lorazepam |
| 9 | Suspect | 20/40 | 82 | Hearing loss, depression, h/o adenoma, arrhythmia, mitral valve prolapse, tinea | Aspirin, colace, miralax |
| 10 | Suspect | 20/20 | 67 | Osteoporosis, depression, gastroesophageal reflux disease, chronic interstitial cystitis | Astelin, estradiol tab, omeprazole, progesterone cream, |
| 11 | Suspect | 20/20 | 70 | Seasonal allergies | Albuterol inhaler, flonase, lovastatin, multivitamin, nabumetone, prilosec, viactiv |
| 12 | Suspect | 20/20 | 74 | Hypertension, diabetes mellitus, arthritis | Digoxin, diltiazem, glipizide, isoniazid, lisinopril, multivitamins, plaquenil sulfate |
| 13 | Suspect | 20/20 | 66 | Hypertension, hypothyroidism, colonic polyps, uterine fibroids | |